Skip to main content
. Author manuscript; available in PMC: 2007 Oct 17.
Published in final edited form as: Circulation. 2007 Apr 2;115(15):1982–1990. doi: 10.1161/CIRCULATIONAHA.106.659763

Table 4. Analysis adjusting for renal function, diabetes, age, sex and body size.

CON (n=617) HTN (n=719) HfnlEF (n=244)
Effective arterial elastance, mmHg/ml 1.30±0.30 1.50±0.41* 1.53±0.43*
End-systolic elastance, mmHg/ml 1.99±0.59 2.30±0.80* 2.39±0.87*
EDVI20, ml/m2 61.7±11.4 59.7±11.9 55.7±14.5*
τ, ms 35.2±23.4 46.8±26.0* 58.1±14.3*

Data are mean ± SD; Comparisons adjusted for glomerular filtration rate, diabetes, age, sex and body surface area (BSA);

*

p<0.05 vs CON;

p<0.05 vs HTN; EDVI, end-diastolic volume indexed to BSA

HHS Vulnerability Disclosure